Compound Deep-Dive

Tier 4: PeptideA powerful neuro-recovery tool that requires medical supervision and a high tolerance for risk and cost.

Cerebrolysin

CereFP-01

Potent brain repair, high barrier.

Hype Risk

4/10

Noticeability

9/10

Evidence Tier

Moderate

Cost / Month

~$240

Medical supervision required

What it's actually good for

Focus

Research Supported

Strong clinical data for cognitive improvement in impaired states.

Recovery

Research Supported

Extensively used for neuro-rehabilitation after stroke or TBI.

Longevity

Weak Evidence

Neuroprotective effects are established, but lifespan data is missing.

Energy: neutralSleep: neutralMuscle: neutralMood: alignedImmunity: neutral

How it works

Cerebrolysin is a porcine-derived peptide mixture used clinically for stroke and dementia. It has moderate evidence for improving cognitive function and supporting neural recovery after injury.

Acts as a neurotrophic factor mimetic that promotes neuronal survival, neurogenesis, and synaptic plasticity.

Safety

Requires sterile injection technique
Risk of anaphylaxis from porcine proteins
Monitor for injection site reactions

The full StackRoast report adds

The exact dose, timing, and effective range to actually run it at
Where people go wrong with it — the dose-creep and timing traps
What Cerebrolysin clashes with or duplicates in your stack

Roast My Stack →

Community Reality Check

Distilled from 1500 threads

Confidence: high

What users report

Lifting brain fog
Improved verbal fluency
Recovery from TBI

The catch

Injection pain
High cost
Ethical concerns (porcine)

Side effects reported

Headache
Sweating
Dizziness

https://www.reddit.com/r/Cerebrolysinhttps://www.reddit.com/r/nootropics

The Receipts

6 sources— studies, videos & links

Videos

Cerebrolysin: The Ultimate Brain Repair Peptide?

Vigorous Steve

A detailed guide on protocols and the science behind Cerebrolysin.

Papers

Zigman et al. (2019)meta-analysis2019

A Cochrane review found that Cerebrolysin may improve cognitive function in patients with vascular dementia.

Alvarez et al. (2011)rct2011

A randomized trial showed significant cognitive improvement in patients with mild-to-moderate Alzheimer's disease.

Creators

Vigorous Steve

YouTube

Known for deep dives into peptide pharmacology and clinical protocols.

Clinical Sources

Examine.comofficial PubMed - Cochrane Reviewclinical

Taking Cerebrolysin in a stack? Find out if the combination actually makes sense.

Roast My Stack →